Trademark applications and grants for Qlt Inc. Qlt Inc has 16 trademark applications. The latest application filed is for "NEW PRODUCTS IN SIGHT"
Patent Application | Date |
---|---|
THERAPEUTIC REGIMEN AND METHODS FOR TREATING OR AMELIORATING VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY 20170087114 - 14/875342 Strong; H. Andrew ;   et al. | 2017-03-30 |
PHARMACEUTICAL FORMULATIONS COMPRISING 9-CIS-RETINYL ESTERS IN A LIPID VEHICLE 20170007565 - 15/274257 Boch; Ronald Erwin | 2017-01-12 |
THERAPEUTIC REGIMENS AND METHODS FOR IMPROVING VISUAL FUNCTION IN VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY 20160296478 - 15/096048 Cadden; Suzanne | 2016-10-13 |
THERAPEUTIC REGIMENS AND METHODS FOR IMPROVING VISUAL FUNCTION IN VISUAL DISORDERS ASSOCIATED WITH AN ENDOGENOUS RETINOID DEFICIENCY 20150038582 - 14/382235 Cadden; Suzanne | 2015-02-05 |
SUSTAINED DELIVERY FORMULATIONS OF RAPAMYCIN COMPOUNDS 20140094484 - 13/633572 Clotaire Margaron; Philippe Maria ;   et al. | 2014-04-03 |
SEC | 0001067947 | QLT INC |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.